Press and Announcements

Please check back frequently for news, announcements, and events.

 

Praetego Wins RESI Longevity Innovator’s Pitch Challenge

September 30, 2021

Praetego wins Innovator’s Pitch Challenge at RESI Longevity

 

Praetego Receives Third Grant from the NIH

June 1, 2021

Praetego Inc, a preclinical stage pharmaceutical company developing novel candidates against chronic diseases of aging, is pleased to announce an award of a $458K grant to study the Amadorin candidates for the treatment of Alzheimer’s Disease.

View press release here.